88 related articles for article (PubMed ID: 2415246)
21. In vivo antitumor activity of S16020, a topoisomerase II inhibitor, and doxorubicin against human brain tumor xenografts.
Vassal G; Merlin JL; Terrier-Lacombe MJ; Grill J; Parker F; Sainte-Rose C; Aubert G; Morizet J; Sévenet N; Poullain MG; Lucas C; Kalifa C
Cancer Chemother Pharmacol; 2003 May; 51(5):385-94. PubMed ID: 12736760
[TBL] [Abstract][Full Text] [Related]
22. Activity of VNP40101M (Cloretazine) in the treatment of CNS tumor xenografts in athymic mice.
Badruddoja MA; Keir ST; King I; Zeidner J; Vredenburgh JJ; Muhlbaier LH; Bigner DD; Friedman HS
Neuro Oncol; 2007 Jul; 9(3):240-4. PubMed ID: 17522334
[TBL] [Abstract][Full Text] [Related]
23. Treatment of intracranial human glioma xenografts with 131I-labeled anti-tenascin monoclonal antibody 81C6.
Lee Y; Bullard DE; Humphrey PA; Colapinto EV; Friedman HS; Zalutsky MR; Coleman RE; Bigner DD
Cancer Res; 1988 May; 48(10):2904-10. PubMed ID: 2452014
[TBL] [Abstract][Full Text] [Related]
24. Human brain tumor xenografts in nude mice as a chemotherapy model.
Houchens DP; Ovejera AA; Riblet SM; Slagel DE
Eur J Cancer Clin Oncol; 1983 Jun; 19(6):799-805. PubMed ID: 6683650
[TBL] [Abstract][Full Text] [Related]
25. Use of the agar diffusion chamber for the exposure of human tumor cells to drugs.
Selby PJ; Steel GG
Cancer Res; 1982 Nov; 42(11):4758-62. PubMed ID: 7127312
[TBL] [Abstract][Full Text] [Related]
26. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
Griswold DP; Trader MW; Frei E; Peters WP; Wolpert MK; Laster WR
Cancer Res; 1987 May; 47(9):2323-7. PubMed ID: 3567926
[TBL] [Abstract][Full Text] [Related]
27. Establishment and characterization of human medulloblastoma xenograft line.
Mikami T; Kurisu K; Kawamoto K; Kiya K; Mukada K; Hotta T; Ogasawara H; Sugiyama K; Uozumi T
Hiroshima J Med Sci; 1991 Mar; 40(1):41-5. PubMed ID: 1864766
[TBL] [Abstract][Full Text] [Related]
28. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.
Vanhoefer U; Cao S; Minderman H; Toth K; Skenderis BS; Slovak ML; Rustum YM
Clin Cancer Res; 1996 Dec; 2(12):1961-8. PubMed ID: 9816155
[TBL] [Abstract][Full Text] [Related]
29. Rapid development of drug resistance in human ovarian tumor xenografts after a single treatment with melphalan in Vivo.
Caffrey PB; Zhang Y; Frenkel GD
Anticancer Res; 1998; 18(4C):3021-5. PubMed ID: 9713503
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic activity of a thioether-lipid conjugate of 1-beta-D-arabinofuranosylcytosine in human colorectal cancer xenografts.
Herrmann R; Berdel WE
Cancer Res; 1992 Apr; 52(7):1865-7. PubMed ID: 1551115
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic analysis of melphalan-resistant human rhabdomyosarcoma xenograft TE-671 MR.
Lilley ER; Elion GB; Dewhirst MW; Schold SC; Blum MR; Savina PM; Laskowitz DT; Bigner DD; Friedman HS
Cancer Res; 1991 Aug; 51(15):3906-9. PubMed ID: 1855207
[TBL] [Abstract][Full Text] [Related]
32. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
[TBL] [Abstract][Full Text] [Related]
33. Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations.
Boland I; Vassal G; Morizet J; Terrier-Lacombe MJ; Valteau-Couanet D; Kalifa C; Hartmann O; Gouyette A
Br J Cancer; 1999 Feb; 79(5-6):787-92. PubMed ID: 10070870
[TBL] [Abstract][Full Text] [Related]
34. Use of phenobarbital and high doses of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the treatment of brain tumor-bearing mice.
Muller PJ; Tator CH; Bloom ML
Cancer Res; 1983 May; 43(5):2068-71. PubMed ID: 6831437
[TBL] [Abstract][Full Text] [Related]
35. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenografts.
Marcantonio D; Panasci LC; Hollingshead MG; Alley MC; Camalier RF; Sausville EA; Dykes DJ; Carter CA; Malspeis L
Cancer Res; 1997 Sep; 57(18):3895-8. PubMed ID: 9307267
[TBL] [Abstract][Full Text] [Related]
36. Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion.
Rosenberg MC; Colvin OM; Griffith OW; Bigner SH; Elion GB; Horton JK; Lilley E; Bigner DD; Friedman HS
Cancer Res; 1989 Dec; 49(24 Pt 1):6917-22. PubMed ID: 2582434
[TBL] [Abstract][Full Text] [Related]
37. Treatment of human brain tumor xenografts with O6-benzyl-2'-deoxyguanosine and BCNU.
Schold SC; Kokkinakis DM; Rudy JL; Moschel RC; Pegg AE
Cancer Res; 1996 May; 56(9):2076-81. PubMed ID: 8616853
[TBL] [Abstract][Full Text] [Related]
38. Specific and high-level targeting of radiolabeled octreotide analogues to human medulloblastoma xenografts.
Vaidyanathan G; Friedman HS; Affleck DJ; Schottelius M; Wester HJ; Zalutsky MR
Clin Cancer Res; 2003 May; 9(5):1868-76. PubMed ID: 12738745
[TBL] [Abstract][Full Text] [Related]
39. Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice.
Zietman AL; Suit HD; Ramsay JR; Silobrcic V; Sedlacek RS
Cancer Res; 1988 Nov; 48(22):6510-6. PubMed ID: 3052803
[TBL] [Abstract][Full Text] [Related]
40. Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy.
Geoerger B; Kerr K; Tang CB; Fung KM; Powell B; Sutton LN; Phillips PC; Janss AJ
Cancer Res; 2001 Feb; 61(4):1527-32. PubMed ID: 11245461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
